Applied DNA CEO James Hayward retires; President Judy Murrah named CEO and Chair

BNB PLUS CORP.

CEO and Chairman James Hayward retires effective June 18, 2025, after 20-year tenure.
Hayward receives $450,000 separation paid over 8 months; first installment by July 15, 2025.
President Judy Murrah appointed CEO, Chairperson, and Board director effective June 18, 2025.
Murrah retains $400,000 annual base salary; no additional board compensation.
Murrah previously President and COO; background includes leadership at Symbol Technologies and Motorola.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Judith Murrah

Chief Executive Officer, Chairperson and Director

BNBX · BNB PLUS CORP.

Effective: 2025-06-18
Filed: June 17, 2025, 7:59 PM ET

On June 17, 2025, the Board elected Judith Murrah, the Company’s current President, as Chief Executive Officer and as Chairperson and a member of the Board effective June 18, 2025.

Departed

Dr. James A. Hayward

Chief Executive Officer, Chairman of the Board and Director

BNBX · BNB PLUS CORP.

Effective: 2025-06-18
Successor: Judith Murrah
Filed: June 17, 2025, 7:59 PM ET

On June 16, 2025, Dr. James A. Hayward informed Applied DNA Sciences, Inc. (the “Company”) of his intention to retire from the Company and that he will step down from his positions as Chief Executive Officer, member of the Company’s board of directors (the “Board”) and Chairman of the Board effective June 18, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Judith Murrah was elected as Chief Executive Officer, Chairperson and Director at BNB PLUS CORP..

Action: elected
Role: Chief Executive Officer, Chairperson and Director

Exact text from the filing

On June 17, 2025, the Board elected Judith Murrah, the Company’s current President, as Chief Executive Officer and as Chairperson and a member of the Board effective June 18, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. James A. Hayward retired as Chief Executive Officer, Chairman of the Board and Director at BNB PLUS CORP..

Action: retired
Role: Chief Executive Officer, Chairman of the Board and Director

Exact text from the filing

On June 16, 2025, Dr. James A. Hayward informed Applied DNA Sciences, Inc. (the “Company”) of his intention to retire from the Company and that he will step down from his positions as Chief Executive Officer, member of the Company’s board of directors (the “Board”) and Chairman of the Board effective June 18, 2025.

View on SEC.gov

BNB PLUS CORP. filing history →

Source: SEC EDGAR

accession 0001104659-25-060258

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.